Prestige Wealth Management Group LLC Purchases 10,116 Shares of Corteva, Inc. $CTVA

Prestige Wealth Management Group LLC grew its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 2,408.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,536 shares of the company’s stock after acquiring an additional 10,116 shares during the period. Prestige Wealth Management Group LLC’s holdings in Corteva were worth $706,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new position in shares of Corteva in the 3rd quarter worth about $25,000. Redmont Wealth Advisors LLC bought a new position in shares of Corteva in the 3rd quarter worth about $29,000. Basepoint Wealth LLC bought a new position in shares of Corteva in the 4th quarter worth about $30,000. Jackson Grant Investment Advisers Inc. raised its position in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC bought a new position in shares of Corteva in the 3rd quarter worth about $33,000. 81.54% of the stock is owned by institutional investors.

Corteva Price Performance

Shares of NYSE CTVA opened at $77.49 on Friday. The firm’s 50-day moving average price is $81.27 and its 200-day moving average price is $74.92. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63. The firm has a market capitalization of $51.82 billion, a P/E ratio of 45.58, a P/E/G ratio of 2.38 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Analyst Ratings Changes

CTVA has been the subject of several research analyst reports. Rothschild & Co Redburn lifted their price objective on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft lifted their price objective on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Mizuho lifted their price objective on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Citigroup upped their price objective on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.